Cargando…

Cancer stem cell targeted therapy: progress amid controversies

Although cancer stem cells have been well characterized in numerous malignancies, the fundamental characteristics of this group of cells, however, have been challenged by some recent observations: cancer stem cells may not necessary to be rare within tumors; cancer stem cells and non-cancer stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Shigdar, Sarah, Gantier, Michael P., Hou, Yingchun, Wang, Li, Li, Yong, Shamaileh, Hadi Al, Yin, Wang, Zhou, Shu-Feng, Zhao, Xinhan, Duan, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792551/
https://www.ncbi.nlm.nih.gov/pubmed/26496035
_version_ 1782421261428719616
author Wang, Tao
Shigdar, Sarah
Gantier, Michael P.
Hou, Yingchun
Wang, Li
Li, Yong
Shamaileh, Hadi Al
Yin, Wang
Zhou, Shu-Feng
Zhao, Xinhan
Duan, Wei
author_facet Wang, Tao
Shigdar, Sarah
Gantier, Michael P.
Hou, Yingchun
Wang, Li
Li, Yong
Shamaileh, Hadi Al
Yin, Wang
Zhou, Shu-Feng
Zhao, Xinhan
Duan, Wei
author_sort Wang, Tao
collection PubMed
description Although cancer stem cells have been well characterized in numerous malignancies, the fundamental characteristics of this group of cells, however, have been challenged by some recent observations: cancer stem cells may not necessary to be rare within tumors; cancer stem cells and non-cancer stem cells may undergo reversible phenotypic changes; and the cancer stem cells phenotype can vary substantially between patients. Here the current status and progresses of cancer stem cells theory is illustrated and via providing a panoramic view of cancer therapy, we addressed the recent controversies regarding the feasibility of cancer stem cells targeted anti-cancer therapy.
format Online
Article
Text
id pubmed-4792551
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-47925512016-03-29 Cancer stem cell targeted therapy: progress amid controversies Wang, Tao Shigdar, Sarah Gantier, Michael P. Hou, Yingchun Wang, Li Li, Yong Shamaileh, Hadi Al Yin, Wang Zhou, Shu-Feng Zhao, Xinhan Duan, Wei Oncotarget Review Although cancer stem cells have been well characterized in numerous malignancies, the fundamental characteristics of this group of cells, however, have been challenged by some recent observations: cancer stem cells may not necessary to be rare within tumors; cancer stem cells and non-cancer stem cells may undergo reversible phenotypic changes; and the cancer stem cells phenotype can vary substantially between patients. Here the current status and progresses of cancer stem cells theory is illustrated and via providing a panoramic view of cancer therapy, we addressed the recent controversies regarding the feasibility of cancer stem cells targeted anti-cancer therapy. Impact Journals LLC 2015-10-19 /pmc/articles/PMC4792551/ /pubmed/26496035 Text en Copyright: © 2015 Wang et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Wang, Tao
Shigdar, Sarah
Gantier, Michael P.
Hou, Yingchun
Wang, Li
Li, Yong
Shamaileh, Hadi Al
Yin, Wang
Zhou, Shu-Feng
Zhao, Xinhan
Duan, Wei
Cancer stem cell targeted therapy: progress amid controversies
title Cancer stem cell targeted therapy: progress amid controversies
title_full Cancer stem cell targeted therapy: progress amid controversies
title_fullStr Cancer stem cell targeted therapy: progress amid controversies
title_full_unstemmed Cancer stem cell targeted therapy: progress amid controversies
title_short Cancer stem cell targeted therapy: progress amid controversies
title_sort cancer stem cell targeted therapy: progress amid controversies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792551/
https://www.ncbi.nlm.nih.gov/pubmed/26496035
work_keys_str_mv AT wangtao cancerstemcelltargetedtherapyprogressamidcontroversies
AT shigdarsarah cancerstemcelltargetedtherapyprogressamidcontroversies
AT gantiermichaelp cancerstemcelltargetedtherapyprogressamidcontroversies
AT houyingchun cancerstemcelltargetedtherapyprogressamidcontroversies
AT wangli cancerstemcelltargetedtherapyprogressamidcontroversies
AT liyong cancerstemcelltargetedtherapyprogressamidcontroversies
AT shamailehhadial cancerstemcelltargetedtherapyprogressamidcontroversies
AT yinwang cancerstemcelltargetedtherapyprogressamidcontroversies
AT zhoushufeng cancerstemcelltargetedtherapyprogressamidcontroversies
AT zhaoxinhan cancerstemcelltargetedtherapyprogressamidcontroversies
AT duanwei cancerstemcelltargetedtherapyprogressamidcontroversies